Yair Schneid Takes 13.073% Stake in Galera Therapeutics
Ticker: GRTX · Form: SC 13G · Filed: Jan 17, 2024 · CIK: 1563577
Complexity: simple
Sentiment: neutral
Topics: insider-ownership, beneficial-ownership, institutional-filing
TL;DR
**Yair Schneid just disclosed a 13.073% stake in Galera Therapeutics, holding over 7.1M shares!**
AI Summary
Yair Schneid, an individual investor, reported beneficial ownership of 7,110,801 shares of Galera Therapeutics, Inc. (GRTX) common stock as of January 5, 2024. This stake represents 13.073% of the company's outstanding shares, making Schneid a significant shareholder. This matters to investors because a large individual stake can signal confidence in the company's future, but also means a single individual holds substantial voting and dispositive power, which could influence corporate decisions.
Why It Matters
A significant individual stake like this can influence company direction and stock performance, as large shareholders often have a louder voice in corporate governance.
Risk Assessment
Risk Level: medium — While a large stake can signal confidence, it also concentrates power, potentially leading to decisions that may not align with all shareholders' interests.
Analyst Insight
Investors should monitor future filings from Yair Schneid (e.g., 13D or subsequent 13G amendments) for any changes in his stake, as significant buying or selling could impact the stock. It's also wise to research Schneid's past investment history if publicly available.
Key Numbers
- 7,110,801 Shares — Shares Beneficially Owned (Represents the total number of shares Yair Schneid has sole voting and dispositive power over.)
- 13.073% — Percentage of Class (Indicates the significant portion of Galera Therapeutics' common stock owned by Yair Schneid.)
- January 5, 2024 — Event Date (The specific date on which Yair Schneid's ownership crossed the threshold requiring this SC 13G filing.)
Key Players & Entities
- Yair Schneid (person) — reporting person and beneficial owner
- Galera Therapeutics, Inc. (company) — subject company (issuer)
- 7,110,801 Shares (dollar_amount) — shares beneficially owned by Yair Schneid
- 13.073% (dollar_amount) — percentage of class represented by Schneid's ownership
- January 5, 2024 (dollar_amount) — date of event requiring the filing
Forward-Looking Statements
- Yair Schneid will maintain a significant stake in Galera Therapeutics for the foreseeable future. (Yair Schneid) — medium confidence, target: Q4 2024
- Galera Therapeutics' stock price will experience increased volatility due to the concentration of ownership. (Galera Therapeutics, Inc.) — low confidence, target: Q3 2024
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Yair Schneid, as stated in 'NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Yair Schneid' on page 2 of the filing.
What is the name of the issuer (subject company) in this filing?
The issuer is Galera Therapeutics Inc., as identified in the 'Name of Issuer' section and 'COMPANY CONFORMED NAME: Galera Therapeutics, Inc.' in the header.
How many shares of Galera Therapeutics, Inc. common stock does Yair Schneid beneficially own?
Yair Schneid beneficially owns 7,110,801 shares, as indicated in 'AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON – 7,110,801 Shares (1)' on page 2.
What percentage of Galera Therapeutics, Inc.'s common stock does Yair Schneid's ownership represent?
Yair Schneid's ownership represents 13.073% of the class, as stated in 'PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 13.073%' on page 2.
What was the date of the event that triggered this SC 13G filing?
The date of the event which required this filing was January 5, 2024, as specified in 'January 5, 2024 (DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)' on page 1.
Filing Stats: 647 words · 3 min read · ~2 pages · Grade level 10 · Accepted 2024-01-16 18:09:24
Key Financial Figures
- $0.001 — OF CLASS OF SECURITIES: Common Shares, $0.001 par value per share ITEM 2 (e) CUSIP N
Filing Documents
- ea191692-13gschneid_galera.htm (SC 13G) — 31KB
- 0001213900-24-003834.txt ( ) — 32KB
(a) NAME OF ISSUER: Galera Therapeutics Inc
ITEM 1 (a) NAME OF ISSUER: Galera Therapeutics Inc.
(b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES
ITEM 1 (b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 45 Liberty Blvd., Suite 230, Malvern, Pennsylvania 19355
(a) NAME OF PERSON FILING: Yair Schneid
ITEM 2 (a) NAME OF PERSON FILING: Yair Schneid
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 1 Wood Lane, Suffern, NY 10901
(c) CITIZENSHIP: USA
ITEM 2 (c) CITIZENSHIP: USA
(d) TITLE OF CLASS OF SECURITIES: Common Shares, $0.001 par
ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Shares, $0.001 par value per share
(e) CUSIP NUMBER: 36338D108
ITEM 2 (e) CUSIP NUMBER: 36338D108
IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B)
ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B): Not applicable
OWNERSHIP
ITEM 4 OWNERSHIP (a) AMOUNT BENEFICIALLY OWNED: 7,110,801 Shares (1) (b) PERCENT OF CLASS: 13.073% (1) (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS: (i) SOLE POWER TO VOTE OR DIRECT THE VOTE 7,110,801 Shares (1) (ii) SHARED POWER TO VOTE OR DIRECT THE VOTE 0 Shares (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 7,110,801 Shares (1) (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF 0 Shares CUSIP No. 36338D108 13G Page 4 of 5 Pages
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS Not applicable
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Not applicable ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY Not applicable
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP Not applicable
NOTICE OF DISSOLUTION OF GROUP
ITEM 9 NOTICE OF DISSOLUTION OF GROUP Not applicable CUSIP No. 36338D108 13G Page 5 of 5 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 16, 2024 (Date) /s/ Yair Schneid (Signature) Yair Schneid (Name/Title)